
- Tissue
- Brain
- Disease
- Rat malignant glioma
- Synonyms
- Luciferase Reporter C6 Cell Line
Documents
C6-Luc
Cell line · Product number 305620
C6-Luc is a genetically modified derivative of the rat C6 glioma cell line, which was originally established from a N-nitrosomethylurea-induced glial brai...
Recommended (freshest lot)
01General information
- Description
C6-Luc is a genetically modified derivative of the rat C6 glioma cell line, which was originally established from a N-nitrosomethylurea-induced glial brain tumour in a Wistar rat by Benda et al. (1968). The parental C6 line was stably transfected with a eukaryotic expression plasmid encoding luciferase under control of a constitutive promoter, followed by selection with hygromycin B to obtain stably expressing monoclonal populations.
C6-Luc cells constitutively express luciferase and emit bioluminescent signal in the presence of a luciferin substrate, enabling real-time, non-invasive monitoring of tumour growth by bioluminescence imaging (BLI) in live animals. The line is used to establish orthotopic syngeneic glioma models in Wistar or Sprague-Dawley rats following intracranial stereotactic implantation, and in subcutaneous xenograft models. Applications include evaluation of anti-glioma therapies, drug penetration across the blood-brain barrier, and development of brain tumour imaging platforms.
- Tissue
- Brain
- Disease
- Rat malignant glioma
- Applications
- Orthotopic rat glioma model for bioluminescence imaging; preclinical evaluation of anti-glioma therapies; blood-brain barrier drug penetration studies; neuroscience and brain tumour research.
- Synonyms
- Luciferase Reporter C6 Cell Line
02Classification
- Organism
- Rat
- Sex
- Male
- Growth properties
- Adherent
- GMO status
- GMO-S1
- GMO status details
- GMO-S1: This cell line contains a stably integrated firefly luciferase reporter cassette (Luc2, codon-optimized) introduced via replication-incompetent lentiviral transduction. The resulting polyclonal cell population was maintained under puromycin selection (1–5 µg/mL). S1 containment is required. This classification applies only within Germany and may differ elsewhere.
- Biosafety level
- 1
03Characteristics
- Morphology
- Polygonal / epithelial-like
- Tumourigenic
- Yes; forms intracranial tumours in syngeneic Wistar/Sprague-Dawley rats
- Doubling time
- 24-48 hours
04Identifiers
- Citation
- C6-Luc (Cytion catalog number 305620)
- NCBI TaxID
- 10116
- Cellosaurus
- CVCL_E3GZ
05Expression and susceptibility
- Antigen expression
- Luc2 (firefly, codon-optimized)
- Products
- Firefly luciferase (luc2, pGL4.50)
06Handling and culture
- Culture medium
- RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
- Incubation atmosphere
37°C, 5% CO2, humidified atmosphere.
- Supplements
- 10% Fetal Bovine Serum
- Dissociation reagent
- Accutase
- Subculturing
- Passage sub-confluent cultures (70–80%) at 1:3 to 1:6 using 0.25% Trypsin/EDTA.
- Seeding density
- 1-3*10^4/cm²
- Thawing and culturing
Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.
Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.
For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.
Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.
Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.
Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.
Follow the procedure described under Post-Thaw Recovery
07Quality control and cryopreservation
- Freeze medium
- As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
- Storage conditions
For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.
- Shipping conditions
Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
08Donor
- Donor age
- Age unspecified
09Legal and safety
- Safety precautions
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments.
- Warranty
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Material Transfer Agreement required
- Yes